This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ahmedin J, Lindsey T, Isabelle S, et al. The Cancer Atlas. 3rd ed. Atlanta: The American Cancer Society; 2019:18–22.AhmedinJLindseyTIsabelleS3rd ed.AtlantaThe American Cancer Society20191822Search in Google Scholar
Chen WQ, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30:1–12.ChenWQSunKXZhengRSCancer incidence and mortality in China, 201420183011210.21147/j.issn.1000-9604.2018.01.01Search in Google Scholar
National Bureau of Statistics of China. China Statistical Yearbook. Beijing: China Statistics Press; 2018 (in Chinese).National Bureau of Statistics of ChinaBeijingChina Statistics Press2018(in Chinese).Search in Google Scholar
Zhao TT. Follow-up survey on quality of life and influencing factors of patients after gynecological malignant tumor surgery. Xinjiang Medical University; 2019 (in Chinese).ZhaoTTXinjiang Medical University2019(in Chinese).Search in Google Scholar
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075.AllemaniCMatsudaTDi CarloVGlobal surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries20183911023107510.1016/S0140-6736(17)33326-3Search in Google Scholar
Berek JS. Berek & Novak's Gynecology. Philadelphia: Lippincott Williams & Wilkins (LWW); 2012.BerekJSPhiladelphiaLippincott Williams & Wilkins (LWW)2012Search in Google Scholar
Qadire MA, Khalaileh MA. Prevalence of symptoms and quality of life among Jordanian cancer patients. Clin Nurs Res. 2014;25:174.QadireMAKhalailehMAPrevalence of symptoms and quality of life among Jordanian cancer patients20142517410.1177/1054773814564212Search in Google Scholar
Nipp RD, Powell E, Chabner BA, et al. Recognizing the financial burden of cancer patients in clinical trials. Oncologist. 2015;20:572–575.NippRDPowellEChabnerBARecognizing the financial burden of cancer patients in clinical trials20152057257510.1634/theoncologist.2015-0068Search in Google Scholar
Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–174.MitchellAJChanMBhattiHPrevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies20111216017410.1016/S1470-2045(11)70002-XSearch in Google Scholar
Liu CL, Liu L, Zhang Y, et al. Prevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study. Health Qual Life Outcomes. 2017;15:161.LiuCLLiuLZhangYPrevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study20171516110.1186/s12955-017-0738-1556163228818112Search in Google Scholar
Yang YL, Liu L, Wang Y, et al. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:393.YangYLLiuLWangYThe prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis20131339310.1186/1471-2407-13-393376587223967823Search in Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: The Association; 2013.American Psychiatric Association5th ed.Washington, DCThe Association201310.1176/appi.books.9780890425596Search in Google Scholar
Linden W, Vodermaier A, Mackenzie R, et al. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141:343–351.LindenWVodermaierAMackenzieRAnxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age201214134335110.1016/j.jad.2012.03.02522727334Search in Google Scholar
Peteet JR, Balboni MJ. Spirituality and religion in oncology. CA Cancer J Clin. 2013;63:280–289.PeteetJRBalboniMJSpirituality and religion in oncology20136328028910.3322/caac.2118723625473Search in Google Scholar
Herzog TJ, Wright JD. The impact of cervical cancer on quality of life – the components and means for management. Gynecol Oncol. 2007;107:572–577.HerzogTJWrightJDThe impact of cervical cancer on quality of life – the components and means for management200710757257710.1016/j.ygyno.2007.09.01917963826Search in Google Scholar
Di MVE, Letizia C, Martina B, et al. Coping mechanisms, psychological distress, and quality of life prior to cancer genetic counseling. Front Psychol. 2018;9:1218.DiMVELetiziaCMartinaBCoping mechanisms, psychological distress, and quality of life prior to cancer genetic counseling20189121810.3389/fpsyg.2018.01218605502530061853Search in Google Scholar
Tercyak KP, Lerman C, Peshkin BN, et al. Effects of coping style and brca1 and brca2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol. 2001;20:217–222.TercyakKPLermanCPeshkinBNEffects of coping style and brca1 and brca2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk20012021722210.1037/0278-6133.20.3.217Search in Google Scholar
Stewart SL, Rim SH, Trivers KF. Summary and impact of ovarian cancer research and programmatic activities at the centers for disease control and prevention. J Womens Health. 2010;19: 1427–1432.StewartSLRimSHTriversKFSummary and impact of ovarian cancer research and programmatic activities at the centers for disease control and prevention2010191427143210.1089/jwh.2010.216420626265Search in Google Scholar
Fairley TL, Pollack LA, Moore AR, et al. Addressing cancer survivorship through public health: an update from the centers for disease control and prevention. J Womens Health, 2009;18: 1525–1531.FairleyTLPollackLAMooreARAddressing cancer survivorship through public health: an update from the centers for disease control and prevention2009181525153110.1089/jwh.2009.166619788367Search in Google Scholar
Zigmond AS. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370.ZigmondASThe Hospital Anxiety and Depression Scale19836736137010.1037/t03589-000Search in Google Scholar
Xie YN. A study on the reliability and validity of the Simple Coping Style Scale. Chin J Clin Psychol. 1998;6:53–54 (in Chinese).XieYNA study on the reliability and validity of the Simple Coping Style Scale199865354(in Chinese).Search in Google Scholar
Price MA, Butow PN, Costa DSJ, et al. Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregiver. Med J Aust. 2010;193(suppl 5):52–57.PriceMAButowPNCostaDSJPrevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregiver2010193suppl 5525710.5694/j.1326-5377.2010.tb03929.x21542447Search in Google Scholar
Yang YL, Liu L, Wang Y, et al. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:393.YangYLLiuLWangYThe prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis20131339310.1186/1471-2407-13-393376587223967823Search in Google Scholar
Sam W, Philip P, Jessica M, et al. Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5:7618.SamWPhilipPJessicaMDepression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates201557618Search in Google Scholar
Mielcarek P, Nowicka-Sauer K, Kozaka J. Anxiety and depression in patients with advanced ovarian cancer: a prospective study. J Psychosom Obstet Gynecol, 2016;37:11.MielcarekPNowicka-SauerKKozakaJAnxiety and depression in patients with advanced ovarian cancer: a prospective study2016371110.3109/0167482X.2016.114189126939616Search in Google Scholar
Hu H, Chen G. Prevalence of depression in Chinese patients with malignant tumor and its related factors. Chin J Clin Oncol Rehabil. 2015;22:636–637 (in Chinese).HuHChenGPrevalence of depression in Chinese patients with malignant tumor and its related factors201522636637(in Chinese).Search in Google Scholar
Dai M, Zhu JL, Fang QL. The efficacy of anti-depression treatment on 286 patients with malignant tumor. China Oncol. 2010;20:857–859 (in Chinese).DaiMZhuJLFangQLThe efficacy of anti-depression treatment on 286 patients with malignant tumor201020857859(in Chinese).Search in Google Scholar
Wang HQ, Ma YL, Li X. Investigation on anxiety, depression and coping styles for patients with bone tumour during chemotherapy. China Med Herald. 2014;11:112–115 (in Chinese).WangHQMaYLLiXInvestigation on anxiety, depression and coping styles for patients with bone tumour during chemotherapy201411112115(in Chinese).Search in Google Scholar
Lutgendorf SK, Shinn E, Carter J, et al. Quality of life among long-term survivors of advanced stage ovarian cancer: a cross-sectional approach. Gynecol Oncol. 2017;146:101–108.LutgendorfSKShinnECarterJQuality of life among long-term survivors of advanced stage ovarian cancer: a cross-sectional approach201714610110810.1016/j.ygyno.2017.05.008561810228527672Search in Google Scholar
Yang YL, Liu L, Li MY, et al. Psychological disorders and psychosocial resources of patients with newly diagnosed bladder and kidney cancer: a cross-sectional study. PloS One. 2016;11:e0155607.YangYLLiuLLiMYPsychological disorders and psychosocial resources of patients with newly diagnosed bladder and kidney cancer: a cross-sectional study201611e015560710.1371/journal.pone.0155607487158227191964Search in Google Scholar
Wu HX, Zhong H, Xu YD, et al. Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131. Neuropsych Dis Treat. 2016;12:1055–1060.WuHXZhongHXuYDPsychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-1312016121055106010.2147/NDT.S105460485942027194911Search in Google Scholar
Costa ALS, Heitkemper MM, Alencar GP, et al. Social support is a predictor of lower stress and higher quality of life and resilience in Brazilian patients with colorectal cancer. Cancer Nurs. 2016;40:1.CostaALSHeitkemperMMAlencarGPSocial support is a predictor of lower stress and higher quality of life and resilience in Brazilian patients with colorectal cancer201640110.1097/NCC.000000000000038827171810Search in Google Scholar
Wang XF, Hong LX. Influence of psychological intervention on the anxiety and depressive symptoms for patients with ovarian cancer in China: a meta-analysis. Mod Med J. 2014;42:248–252 (in Chinese).WangXFHongLXInfluence of psychological intervention on the anxiety and depressive symptoms for patients with ovarian cancer in China: a meta-analysis201442248252(in Chinese).Search in Google Scholar